Fortis Pharma Consulting Limited - Limited company - abbreviated - 11.6

Fortis Pharma Consulting Limited - Limited company - abbreviated - 11.6


05390470 1.4.14 31.3.15 31.3.15 Company accounts Private Limited Company FY true false true false true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure053904702014-03-31053904702015-03-31053904702014-04-012015-03-31053904702013-03-31053904702013-04-012014-03-31053904702014-03-3105390470ns12:England2014-04-012015-03-3105390470ns14:PoundSterling2014-04-012015-03-3105390470ns7:Director12014-04-012015-03-3105390470ns7:Director22014-04-012015-03-3105390470ns7:OrdinaryShareClass12014-04-012015-03-3105390470ns7:CompanySecretary2014-04-012015-03-3105390470ns7:RegisteredOffice2014-04-012015-03-3105390470ns7:EntityAccountantsOrAuditors2014-04-012015-03-3105390470ns5:PlantMachinery2014-04-012015-03-3105390470ns5:FixedAssetInvestmentsOtherThanLoans2015-03-3105390470ns5:Subsidiary12014-04-012015-03-3105390470ns7:OrdinaryShareClass12015-03-3105390470ns7:OrdinaryShareClass12014-03-31
REGISTERED NUMBER: 05390470 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 March 2015

for

Fortis Pharma Consulting Limited

Fortis Pharma Consulting Limited (Registered number: 05390470)






Contents of the Abbreviated Accounts
for the Year Ended 31 March 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Fortis Pharma Consulting Limited

Company Information
for the Year Ended 31 March 2015







DIRECTORS: G Smith
M Stanton





SECRETARY: S Bennett





REGISTERED OFFICE: 22 Great James Street
London
WC1N 3ES





REGISTERED NUMBER: 05390470 (England and Wales)





ACCOUNTANTS: Caroline Gibbons ACA CTA
26 Eastwick Drive
Great Bookham
Leatherhead
Surrey
KT23 3PR

Fortis Pharma Consulting Limited (Registered number: 05390470)

Abbreviated Balance Sheet
31 March 2015

31.3.15 31.3.14
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 68,750 75,625
Tangible assets 3 4,556 4,851
Investments 4 6 -
73,312 80,476

CURRENT ASSETS
Debtors 5 615,347 627,544
Cash at bank and in hand 124,324 156,807
739,671 784,351
CREDITORS
Amounts falling due within one year 125,301 162,938
NET CURRENT ASSETS 614,370 621,413
TOTAL ASSETS LESS CURRENT
LIABILITIES

687,682

701,889

PROVISIONS FOR LIABILITIES 911 970
NET ASSETS 686,771 700,919

CAPITAL AND RESERVES
Called up share capital 6 2 2
Profit and loss account 686,769 700,917
SHAREHOLDERS' FUNDS 686,771 700,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Fortis Pharma Consulting Limited (Registered number: 05390470)

Abbreviated Balance Sheet - continued
31 March 2015


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 17 July 2015 and were signed on its behalf by:




G Smith - Director



M Stanton - Director


Fortis Pharma Consulting Limited (Registered number: 05390470)

Notes to the Abbreviated Accounts
for the Year Ended 31 March 2015

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax, except in respect of service contracts
where turnover is recognised when the company obtains the right to consideration.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2005, is being amortised evenly over its estimated useful life of twenty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 33% on cost and 25% on cost

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to the profit and loss account in the period to which they relate.

2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2014
and 31 March 2015 137,500
AMORTISATION
At 1 April 2014 61,875
Amortisation for year 6,875
At 31 March 2015 68,750
NET BOOK VALUE

At 31 March 2015 68,750
At 31 March 2014 75,625

Fortis Pharma Consulting Limited (Registered number: 05390470)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 March 2015

3. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2014 9,374
Additions 3,846
Disposals (1,436 )
At 31 March 2015 11,784
DEPRECIATION
At 1 April 2014 4,523
Charge for year 3,458
Eliminated on disposal (753 )
At 31 March 2015 7,228
NET BOOK VALUE
At 31 March 2015 4,556
At 31 March 2014 4,851

4. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
Additions 6
At 31 March 2015 6
NET BOOK VALUE
At 31 March 2015 6

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Fortis Digital Ltd
Nature of business: Dormant
%
Class of shares: holding
Ordinary 60.00

5. DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

The aggregate total of debtors falling due after more than one year is £ 517,316 (31.3.14 - £ 525,523 )

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.15 31.3.14
value: £    £   
2 Ordinary £1 2 2

Fortis Pharma Consulting Limited (Registered number: 05390470)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 March 2015

7. ULTIMATE PARENT COMPANY

Azimuth Pharma Ltd is regarded by the directors as being the company's ultimate parent company.